Suppr超能文献

采用人肝微粒体孵育和高分辨质谱法研究吲哚甲酰胺类合成大麻素 MDMB-CHMINACA 的体外 I 相代谢。

In vitro Phase I metabolism of indazole carboxamide synthetic cannabinoid MDMB-CHMINACA via human liver microsome incubation and high-resolution mass spectrometry.

机构信息

Temple University Department of Chemistry, Philadelphia, Pennsylvania, United States.

The Center for Forensic Science Research and Education at the Fredric Rieders Family Foundation, Willow Grove, Pennsylvania, United States.

出版信息

Drug Test Anal. 2019 Aug;11(8):1264-1276. doi: 10.1002/dta.2615. Epub 2019 Jun 9.

Abstract

Synthetic cannabinoids have proliferated over the last decade and have become a major public health and analytical challenge, critically impacting the clinical and forensic communities. Indazole carboxamide class synthetic cannabinoids have been particularly rampant, and exhibit severe toxic effects upon consumption due to their high binding affinity and potency at the cannabinoid receptors (CB and CB ). MDMB-CHMINACA, methyl 2-[1-(cyclohexylmethyl)-1H-indazole-3-carboxamido]-3,3-dimethylbutanoate, a compound of this chemical class, has been identified in forensic casework and is structurally related to several other synthetic cannabinoids. This study presents the first extensive report on the Phase I metabolic profile of MDMB-CHMINACA, a potent synthetic cannabinoid. The in vitro metabolism of MDMB-CHMINACA was determined via incubation with human liver microsomes and high-resolution mass spectrometry. The accurate masses of precursor and fragments, mass error (ppm), and chemical formula were obtained for each metabolite. Twenty-seven metabolites were identified, encompassing twelve metabolite types. The major biotransformations observed were hydroxylation and ester hydrolysis. Hydroxylations were located predominantly on the cyclohexylmethyl (CHM) moiety. Ester hydrolysis was followed by additional biotransformations, including dehydrogenation; mono- and dihydroxylation and ketone formation, each with dehydrogenation. Minor metabolites were identified and reported. The authors propose that CHM-monohydroxylated metabolites specific to MDMB-CHMINACA are the most suitable candidates for implementation into bioanalytical assays to demonstrate consumption of this synthetic cannabinoid. Due to the structural similarity of MDMB-CHMINACA and currently trending synthetic cannabinoids whose metabolic profiles have not been reported, the results of this study can be used as a guide to predict their metabolic pathways.

摘要

合成大麻素在过去十年中迅速蔓延,已成为主要的公共卫生和分析挑战,对临床和法医界产生了重大影响。吲唑甲酰胺类合成大麻素尤其猖獗,由于其与大麻素受体(CB 和 CB )的高亲和力和效力,在消耗后会产生严重的毒性作用。MDMB-CHMINACA,即甲基 2-[1-(环己基甲基)-1H-吲唑-3-羧酰胺基]-3,3-二甲基丁酸盐,是该化学物质类别的一种化合物,已在法医工作中被发现,与其他几种合成大麻素在结构上有关。本研究首次全面报告了 MDMB-CHMINACA 的 I 期代谢特征,MDMB-CHMINACA 是一种有效的合成大麻素。通过与人肝微粒体孵育和高分辨率质谱法来确定 MDMB-CHMINACA 的体外代谢。每个代谢物都获得了前体和片段的精确质量、质量误差(ppm)和化学式。鉴定出 27 种代谢物,包含 12 种代谢物类型。观察到的主要生物转化是羟化和酯水解。羟化主要发生在环己基甲基(CHM)部分。酯水解后,发生其他生物转化,包括脱氢;单和二羟化和酮形成,每个都带有脱氢。鉴定并报告了少量代谢物。作者提出,MDMB-CHMINACA 特有的 CHM-单羟基化代谢物是最适合纳入生物分析测定以证明消耗该合成大麻素的候选物。由于 MDMB-CHMINACA 与目前流行的尚未报道代谢特征的合成大麻素结构相似,因此本研究的结果可作为预测其代谢途径的指南。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验